A carregar...
Publicação
Prodrug Systems (I): Lipid-based Doxorubicin Prodrugs and their nanodelivery systems
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 517.97 KB | Adobe PDF |
Orientador(es)
Resumo(s)
Using natural lipids to covalently connect with antitumor agents to construct lipid-based molecular
prodrugs and their nanosystems is a promising research frontier for sustainable medicinal chemistry,
nanobiotechnology and tumor chemotherapy. This paper reviewed recent progress of lipid-based doxorubicin
(molecular) prodrugs and their nanodelivery systems, including lipid-doxorubicin prodrugs, stimuli-responsive
lipid-doxorubicin prodrugs, and lipid-doxorubicin prodrug-based drug co-delivery nanosystems. Additionally,
possible future research outlooks in this field were also discussed.
Descrição
Palavras-chave
Lipid Doxorubicin Prodrugs Stimuli-responsive Drug co-delivery Nanosystems . Faculdade de Ciências Exatas e da Engenharia Centro de Química da Madeira
Contexto Educativo
Citação
Olim, F., Neves, A. R., Wang, Z., Sun, J., Tomás, H., & Sheng, R. (2020). Prodrug Systems (I): Lipid-based Doxorubicin Prodrugs and their nanodelivery systems. Medicine Research, 4(1-2), 200013. DOI: 10.21127/yaoyimr20200013
Editora
Medicine Research